...BioTime's LifeMap Sciences Inc. subsidiary completed its acquisition of XenneX in a stock deal. XenneX shareholders... ...Rehovot, Israel). Details were not disclosed (see BioCentury, April 30). BioTime Inc. (NYSE-A:BTX), Alameda, Calif. XenneX Inc....
...deal. XenneX shareholders will receive 1.4 million shares, or about 13% common shares of LifeMap. XenneX... ...Inc. (NYSE-A:BTX), Alameda, Calif. XenneX Inc. , Cambridge, Mass. BioTime's LifeMap Sciences Inc. subsidiary will acquire XenneX... ...deal. XenneX shareholders will receive 1.4 million shares, or about 13% common shares of LifeMap. XenneX...
...The parties announced ABI's TaqMan Genomic Assays will be accessible via Xennex's GeneCards database of human... ...direct access to its collection of genomic assays. Applied Biosystems Group (ABI), Foster City, Calif. Xennex Inc....
...BioTime's LifeMap Sciences Inc. subsidiary completed its acquisition of XenneX in a stock deal. XenneX shareholders... ...Rehovot, Israel). Details were not disclosed (see BioCentury, April 30). BioTime Inc. (NYSE-A:BTX), Alameda, Calif. XenneX Inc....
...deal. XenneX shareholders will receive 1.4 million shares, or about 13% common shares of LifeMap. XenneX... ...Inc. (NYSE-A:BTX), Alameda, Calif. XenneX Inc. , Cambridge, Mass. BioTime's LifeMap Sciences Inc. subsidiary will acquire XenneX... ...deal. XenneX shareholders will receive 1.4 million shares, or about 13% common shares of LifeMap. XenneX...
...The parties announced ABI's TaqMan Genomic Assays will be accessible via Xennex's GeneCards database of human... ...direct access to its collection of genomic assays. Applied Biosystems Group (ABI), Foster City, Calif. Xennex Inc....